A Phase IV Study of the Safety and Efficacy of CinnoPar® in Iranian Patients with Osteoporosis.
Jamshidi A, Gharibdoost F, Sedighi S, Hajiabbasi A, Salari AH, Khabbazi A, Mottaghi P, Tahammoli Roudsari A, Aghaei M, Shenavar Masooleh I, Sabzvari A, Anjidani N.
Jamshidi A, et al. Among authors: mottaghi p.
J Osteoporos. 2021 May 31;2021:7584308. doi: 10.1155/2021/7584308. eCollection 2021.
J Osteoporos. 2021.
PMID: 34194720
Free PMC article.